ropivacaine hydrochloride

FDA Drug Profile — ropivacaine hydrochloride, Naropin, ROPIVACAINE HYDROCHLORIDE, NAROPIN

ropivacaine hydrochloride is listed in the FDA National Drug Code directory with 11 NDC codes, marketed under brand names including ropivacaine hydrochloride, Naropin, ROPIVACAINE HYDROCHLORIDE. Available dosage forms: injection, solution, injection, powder.

Drug details

Generic Name
ropivacaine hydrochloride
Brand Names
ropivacaine hydrochloride, Naropin, ROPIVACAINE HYDROCHLORIDE, NAROPIN
Application Number
ANDA206166
Sponsor
Sagent Pharmaceuticals
NDC Codes
11
Dosage Forms
INJECTION, SOLUTION, INJECTION, POWDER
Routes
EPIDURAL, INFILTRATION, PERINEURAL
Active Ingredients
ROPIVACAINE HYDROCHLORIDE

Indications and Usage

1 Indications and Usage NAROPIN is indicated for the production of local or regional anesthesia for surgery and for acute pain management. Surgical Anesthesia : epidural block for surgery including cesarean section; major nerve block; local infiltration Acute Pain Management : epidural continuous infusion or intermittent bolus, e.g., postoperative or labor; local infiltration NAROPIN is an amide local anesthetic indicated in adults for the production of local or regional anesthesia for surgery and for acute pain management. (1) Surgical Anesthesia : epidural block for surgery including cesarean section; major nerve block; local infiltration Acute Pain Management : epidural continuous infusion or intermittent bolus, e.g., postoperative or labor; local infiltration

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.